| negative regulation of striated muscle tissue development | GO:0045843 | 11 | 0.989 | |
| mesodermal cell fate specification | GO:0007501 | 2 | 0.988 | |
| mesodermal cell fate commitment | GO:0001710 | 2 | 0.987 | |
| embryonic forelimb morphogenesis | GO:0035115 | 4 | 0.985 | |
| cardiac right ventricle formation | GO:0003219 | 1 | 0.981 | |
| embryonic camera type eye formation | GO:0060900 | 2 | 0.978 | |
| positive regulation of monocyte chemotactic protein 1 production | GO:0071639 | 3 | 0.971 | |
| cardiac chamber formation | GO:0003207 | 2 | 0.962 | |
| cardiac ventricle formation | GO:0003211 | 2 | 0.960 | |
| embryonic camera type eye development | GO:0031076 | 2 | 0.947 | |
| aortic valve development | GO:0003176 | 3 | 0.944 | |
| neural crest cell development | GO:0014032 | 3 | 0.931 | |
| blood vessel maturation | GO:0001955 | 1 | 0.925 | |
| hindbrain development | GO:0030902 | 3 | 0.899 | |
| forelimb morphogenesis | GO:0035136 | 4 | 0.883 | |
| hindlimb morphogenesis | GO:0035137 | 2 | 0.877 | |
| salivary gland morphogenesis | GO:0007435 | 4 | 0.876 | |
| cell proliferation involved in heart valve development | GO:2000793 | 1 | 0.869 | |
| cardiac left ventricle formation | GO:0003218 | 1 | 0.852 | |
| nerve development | GO:0021675 | 4 | 0.850 | |
| negative regulation of muscle tissue development | GO:1901862 | 11 | 0.826 | |
| internal protein amino acid acetylation | GO:0006475 | 101 | 0.816 | |
| regulation of myeloid cell differentiation | GO:0045637 | 81 | 0.813 | |
| cranial nerve development | GO:0021545 | 4 | 0.805 | |
| positive regulation of chromatin assembly or disassembly | GO:0045799 | 2 | 0.755 | |
| aortic valve morphogenesis | GO:0003180 | 3 | 0.754 | |
| negative regulation of histone phosphorylation | GO:0033128 | 2 | 0.751 | |
| cell fate commitment involved in formation of primary germ layer | GO:0060795 | 6 | 0.738 | |
| eyelid development in camera type eye | GO:0061029 | 2 | 0.738 | |
| neural tube formation | GO:0001841 | 3 | 0.735 | |
| negative regulation of phosphatidylinositol 3 kinase signaling | GO:0014067 | 4 | 0.729 | |
| mitral valve development | GO:0003174 | 3 | 0.722 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 4 | 0.706 | |
| heart valve formation | GO:0003188 | 2 | 0.702 | |
| monocarboxylic acid metabolic process | GO:0032787 | 185 | 0.694 | |
| trophectodermal cell differentiation | GO:0001829 | 3 | 0.663 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 50 | 0.662 | |
| embryonic eye morphogenesis | GO:0048048 | 2 | 0.648 | |
| regulation of heart morphogenesis | GO:2000826 | 4 | 0.634 | |
| covalent chromatin modification | GO:0016569 | 254 | 0.626 | |
| neural crest cell migration | GO:0001755 | 2 | 0.624 | |
| basophil differentiation | GO:0030221 | 2 | 0.612 | |
| positive regulation of stem cell differentiation | GO:2000738 | 29 | 0.599 | |
| chromatin modification | GO:0016568 | 298 | 0.588 | |
| craniofacial suture morphogenesis | GO:0097094 | 3 | 0.587 | |
| myeloid cell differentiation | GO:0030099 | 117 | 0.573 | |
| endocardial cushion development | GO:0003197 | 3 | 0.572 | |
| cellular amine metabolic process | GO:0044106 | 41 | 0.570 | |
| atrioventricular valve development | GO:0003171 | 3 | 0.569 | |
| embryonic camera type eye morphogenesis | GO:0048596 | 2 | 0.559 | |
| chromatin organization | GO:0006325 | 351 | 0.552 | |
| regulation of bone mineralization | GO:0030500 | 29 | 0.547 | |
| histone acetylation | GO:0016573 | 93 | 0.539 | |
| peptidyl lysine modification | GO:0018205 | 144 | 0.523 | |
| mesodermal cell differentiation | GO:0048333 | 10 | 0.499 | |
| cellular ketone metabolic process | GO:0042180 | 80 | 0.486 | |
| embryonic epithelial tube formation | GO:0001838 | 4 | 0.474 | |
| mitral valve morphogenesis | GO:0003183 | 2 | 0.461 | |
| negative regulation of muscle organ development | GO:0048635 | 12 | 0.460 | |
| blastocyst formation | GO:0001825 | 3 | 0.451 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 89 | 0.449 | |
| cardiac septum morphogenesis | GO:0060411 | 9 | 0.444 | |
| embryonic cranial skeleton morphogenesis | GO:0048701 | 6 | 0.438 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 6 | 0.428 | |
| internal peptidyl lysine acetylation | GO:0018393 | 97 | 0.423 | |
| optic nerve development | GO:0021554 | 2 | 0.423 | |
| peptide transport | GO:0015833 | 74 | 0.422 | |
| lipid metabolic process | GO:0006629 | 381 | 0.417 | |
| regulation of biomineral tissue development | GO:0070167 | 31 | 0.417 | |
| chromatin assembly or disassembly | GO:0006333 | 78 | 0.415 | |
| positive regulation of myeloid cell differentiation | GO:0045639 | 39 | 0.414 | |
| peptidyl lysine acetylation | GO:0018394 | 101 | 0.411 | |
| regulation of muscle tissue development | GO:1901861 | 26 | 0.402 | |
| primary neural tube formation | GO:0014020 | 3 | 0.394 | |
| negative regulation of skeletal muscle tissue development | GO:0048642 | 2 | 0.393 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 44 | 0.386 | |
| protein acylation | GO:0043543 | 138 | 0.376 | |
| regulation of cellular amine metabolic process | GO:0033238 | 11 | 0.374 | |
| amine metabolic process | GO:0009308 | 44 | 0.374 | |
| cerebellum development | GO:0021549 | 2 | 0.373 | |
| negative regulation of cytokine production | GO:0001818 | 82 | 0.359 | |
| megakaryocyte differentiation | GO:0030219 | 25 | 0.356 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 3 | 0.355 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 211 | 0.347 | |
| cellular lipid metabolic process | GO:0044255 | 303 | 0.345 | |
| positive regulation of epithelial to mesenchymal transition | GO:0010718 | 22 | 0.343 | |
| atrioventricular valve morphogenesis | GO:0003181 | 2 | 0.341 | |
| dna repair | GO:0006281 | 198 | 0.340 | |
| embryonic hindlimb morphogenesis | GO:0035116 | 2 | 0.339 | |
| regulation of lipid catabolic process | GO:0050994 | 23 | 0.336 | |
| peptide hormone secretion | GO:0030072 | 50 | 0.336 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 2 | 0.334 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 38 | 0.328 | |
| double strand break repair | GO:0006302 | 101 | 0.323 | |
| lipid catabolic process | GO:0016042 | 84 | 0.312 | |
| mesenchymal cell development | GO:0014031 | 50 | 0.310 | |
| metencephalon development | GO:0022037 | 2 | 0.304 | |
| regulation of epithelial to mesenchymal transition | GO:0010717 | 37 | 0.303 | |
| immune system development | GO:0002520 | 195 | 0.300 | |
| positive regulation of lipid catabolic process | GO:0050996 | 13 | 0.299 | |
| neural tube closure | GO:0001843 | 3 | 0.293 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 50 | 0.286 | |
| cellular amino acid metabolic process | GO:0006520 | 116 | 0.284 | |
| lipid modification | GO:0030258 | 84 | 0.279 | |
| negative regulation of transcription from rna polymerase ii promoter | GO:0000122 | 281 | 0.276 | |
| cellular response to dna damage stimulus | GO:0006974 | 379 | 0.271 | |
| pancreas development | GO:0031016 | 19 | 0.270 | |
| embryonic digit morphogenesis | GO:0042733 | 6 | 0.266 | |
| carboxylic acid catabolic process | GO:0046395 | 71 | 0.265 | |
| regulation of tumor necrosis factor production | GO:0032680 | 43 | 0.264 | |
| regulation of hormone levels | GO:0010817 | 125 | 0.264 | |
| regulation of dna repair | GO:0006282 | 47 | 0.264 | |
| dna damage response signal transduction by p53 class mediator | GO:0030330 | 44 | 0.262 | |
| regulation of mitotic cell cycle | GO:0007346 | 189 | 0.262 | |
| positive regulation of erythrocyte differentiation | GO:0045648 | 11 | 0.261 | |
| cellular lipid catabolic process | GO:0044242 | 65 | 0.261 | |
| regulation of muscle organ development | GO:0048634 | 27 | 0.256 | |
| oxidation reduction process | GO:0055114 | 396 | 0.253 | |
| regulation of response to dna damage stimulus | GO:2001020 | 94 | 0.253 | |
| regulation of striated muscle tissue development | GO:0016202 | 26 | 0.248 | |
| cardiac chamber development | GO:0003205 | 30 | 0.242 | |
| positive regulation of binding | GO:0051099 | 45 | 0.242 | |
| regulation of stem cell differentiation | GO:2000736 | 56 | 0.239 | |
| second messenger mediated signaling | GO:0019932 | 78 | 0.235 | |
| small molecule catabolic process | GO:0044282 | 92 | 0.234 | |
| tube closure | GO:0060606 | 3 | 0.234 | |
| blastocyst development | GO:0001824 | 3 | 0.234 | |
| positive regulation of cellular component organization | GO:0051130 | 376 | 0.232 | |
| cytokine production | GO:0001816 | 247 | 0.227 | |
| ventricular cardiac muscle tissue morphogenesis | GO:0055010 | 14 | 0.226 | |
| muscle organ morphogenesis | GO:0048644 | 19 | 0.226 | |
| positive regulation of secretion | GO:0051047 | 116 | 0.218 | |
| fatty acid metabolic process | GO:0006631 | 115 | 0.218 | |
| regulation of cell cycle | GO:0051726 | 393 | 0.214 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 14 | 0.214 | |
| peptide secretion | GO:0002790 | 51 | 0.213 | |
| regulation of fatty acid beta oxidation | GO:0031998 | 8 | 0.213 | |
| epithelial to mesenchymal transition | GO:0001837 | 48 | 0.207 | |
| organic acid catabolic process | GO:0016054 | 71 | 0.206 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 65 | 0.203 | |
| myeloid leukocyte differentiation | GO:0002573 | 60 | 0.202 | |
| cation transport | GO:0006812 | 331 | 0.197 | |
| lipid oxidation | GO:0034440 | 33 | 0.195 | |
| regulation of transmembrane transporter activity | GO:0022898 | 74 | 0.194 | |
| regulation of double strand break repair | GO:2000779 | 22 | 0.194 | |
| hormone secretion | GO:0046879 | 65 | 0.194 | |
| regulation of protein localization | GO:0032880 | 296 | 0.189 | |
| bone mineralization | GO:0030282 | 34 | 0.189 | |
| negative regulation of transmembrane transport | GO:0034763 | 29 | 0.188 | |
| mitotic cell cycle | GO:0000278 | 326 | 0.182 | |
| positive regulation of cell cycle | GO:0045787 | 140 | 0.181 | |
| negative regulation of histone acetylation | GO:0035067 | 6 | 0.178 | |
| nitrogen compound transport | GO:0071705 | 191 | 0.176 | |
| positive regulation of cytokine production | GO:0001819 | 167 | 0.174 | |
| negative regulation of programmed cell death | GO:0043069 | 321 | 0.173 | |
| embryonic appendage morphogenesis | GO:0035113 | 9 | 0.172 | |
| regulation of cytokine production | GO:0001817 | 232 | 0.171 | |
| formation of primary germ layer | GO:0001704 | 42 | 0.168 | |
| negative regulation of tumor necrosis factor production | GO:0032720 | 20 | 0.168 | |
| stem cell development | GO:0048864 | 69 | 0.167 | |
| regulation of secretion by cell | GO:1903530 | 177 | 0.166 | |
| cell aging | GO:0007569 | 52 | 0.166 | |
| hemopoiesis | GO:0030097 | 180 | 0.164 | |
| cardiac ventricle development | GO:0003231 | 23 | 0.164 | |
| mesoderm formation | GO:0001707 | 10 | 0.163 | |
| osteoblast differentiation | GO:0001649 | 92 | 0.162 | |
| fatty acid catabolic process | GO:0009062 | 29 | 0.161 | |
| regulation of establishment of protein localization | GO:0070201 | 242 | 0.159 | |
| odontogenesis | GO:0042476 | 25 | 0.159 | |
| regulation of transcription regulatory region dna binding | GO:2000677 | 15 | 0.159 | |
| amide transport | GO:0042886 | 76 | 0.158 | |
| chemokine production | GO:0032602 | 32 | 0.157 | |
| cardiac chamber morphogenesis | GO:0003206 | 26 | 0.157 | |
| regulation of histone acetylation | GO:0035065 | 19 | 0.155 | |
| regulation of cellular component biogenesis | GO:0044087 | 281 | 0.154 | |
| monocarboxylic acid catabolic process | GO:0072329 | 37 | 0.152 | |
| regulation of erythrocyte differentiation | GO:0045646 | 17 | 0.150 | |
| monovalent inorganic cation transport | GO:0015672 | 128 | 0.149 | |
| regulation of protein transport | GO:0051223 | 213 | 0.146 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 158 | 0.146 | |
| positive regulation of cellular component movement | GO:0051272 | 181 | 0.146 | |
| regulation of cytokine secretion | GO:0050707 | 57 | 0.143 | |
| negative regulation of protein metabolic process | GO:0051248 | 391 | 0.142 | |
| regulation of lipid metabolic process | GO:0019216 | 96 | 0.142 | |
| positive regulation of dna binding | GO:0043388 | 17 | 0.142 | |
| positive regulation of secretion by cell | GO:1903532 | 108 | 0.142 | |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 131 | 0.142 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 353 | 0.141 | |
| regulation of dna binding | GO:0051101 | 37 | 0.141 | |
| regulation of transmembrane transport | GO:0034762 | 139 | 0.141 | |
| monocyte chemotactic protein 1 production | GO:0071605 | 6 | 0.140 | |
| negative regulation of cell death | GO:0060548 | 345 | 0.138 | |
| positive regulation of transport | GO:0051050 | 336 | 0.137 | |
| positive regulation of organelle organization | GO:0010638 | 195 | 0.136 | |
| positive regulation of cell proliferation | GO:0008284 | 301 | 0.135 | |
| embryonic limb morphogenesis | GO:0030326 | 9 | 0.135 | |
| regulation of secretion | GO:0051046 | 194 | 0.134 | |
| actin filament based process | GO:0030029 | 224 | 0.133 | |
| signal transduction in response to dna damage | GO:0042770 | 57 | 0.132 | |
| negative regulation of histone modification | GO:0031057 | 19 | 0.131 | |
| negative regulation of cellular component organization | GO:0051129 | 235 | 0.131 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 186 | 0.131 | |
| cardiac muscle tissue development | GO:0048738 | 39 | 0.131 | |
| regulation of ion transport | GO:0043269 | 189 | 0.131 | |
| hydrogen transport | GO:0006818 | 23 | 0.130 | |
| interleukin 6 production | GO:0032635 | 37 | 0.129 | |
| regulation of binding | GO:0051098 | 111 | 0.128 | |
| muscle tissue development | GO:0060537 | 62 | 0.128 | |
| negative regulation of cellular senescence | GO:2000773 | 5 | 0.127 | |
| positive regulation of catabolic process | GO:0009896 | 310 | 0.127 | |
| bone development | GO:0060348 | 26 | 0.127 | |
| positive regulation of cell motility | GO:2000147 | 177 | 0.127 | |
| mesenchymal cell differentiation | GO:0048762 | 52 | 0.123 | |
| regulation of cell differentiation | GO:0045595 | 393 | 0.123 | |
| positive regulation of protein transport | GO:0051222 | 135 | 0.122 | |
| hormone transport | GO:0009914 | 68 | 0.121 | |
| regulation of transporter activity | GO:0032409 | 82 | 0.121 | |
| gland morphogenesis | GO:0022612 | 8 | 0.119 | |
| regulation of cellular senescence | GO:2000772 | 13 | 0.118 | |
| histone modification | GO:0016570 | 251 | 0.117 | |
| cellular response to oxygen levels | GO:0071453 | 55 | 0.116 | |
| anatomical structure formation involved in morphogenesis | GO:0048646 | 284 | 0.116 | |
| signal release | GO:0023061 | 70 | 0.115 | |
| regulation of cellular response to stress | GO:0080135 | 244 | 0.115 | |
| cellular response to decreased oxygen levels | GO:0036294 | 51 | 0.115 | |
| epithelial tube morphogenesis | GO:0060562 | 38 | 0.115 | |
| appendage morphogenesis | GO:0035107 | 16 | 0.114 | |
| regulation of signal transduction by p53 class mediator | GO:1901796 | 26 | 0.113 | |
| positive regulation of cellular catabolic process | GO:0031331 | 284 | 0.111 | |
| regulation of peroxisome proliferator activated receptor signaling pathway | GO:0035358 | 4 | 0.110 | |
| erythrocyte homeostasis | GO:0034101 | 31 | 0.109 | |
| fatty acid oxidation | GO:0019395 | 31 | 0.109 | |
| positive regulation of fatty acid metabolic process | GO:0045923 | 11 | 0.108 | |
| negative regulation of developmental process | GO:0051093 | 247 | 0.108 | |
| cellular senescence | GO:0090398 | 34 | 0.108 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 83 | 0.107 | |
| positive regulation of locomotion | GO:0040017 | 186 | 0.106 | |
| proton transport | GO:0015992 | 22 | 0.106 | |
| positive regulation of fatty acid beta oxidation | GO:0032000 | 5 | 0.105 | |
| secretion by cell | GO:0032940 | 226 | 0.105 | |
| negative regulation of organelle organization | GO:0010639 | 126 | 0.104 | |
| regulation of cellular component movement | GO:0051270 | 334 | 0.103 | |
| tumor necrosis factor superfamily cytokine production | GO:0071706 | 45 | 0.102 | |
| regulation of fatty acid metabolic process | GO:0019217 | 24 | 0.102 | |
| negative regulation of transport | GO:0051051 | 176 | 0.101 | |
| heart morphogenesis | GO:0003007 | 48 | 0.099 | |
| negative regulation of multicellular organismal process | GO:0051241 | 317 | 0.098 | |
| positive regulation of cell development | GO:0010720 | 92 | 0.095 | |
| cellular response to hypoxia | GO:0071456 | 51 | 0.095 | |
| intracellular receptor signaling pathway | GO:0030522 | 104 | 0.094 | |
| negative regulation of response to dna damage stimulus | GO:2001021 | 33 | 0.093 | |
| positive regulation of tumor necrosis factor superfamily cytokine production | GO:1903557 | 22 | 0.092 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 267 | 0.092 | |
| granulocyte differentiation | GO:0030851 | 16 | 0.092 | |
| positive regulation of protein secretion | GO:0050714 | 60 | 0.090 | |
| negative regulation of chromatin modification | GO:1903309 | 21 | 0.090 | |
| negative regulation of cell differentiation | GO:0045596 | 171 | 0.090 | |
| striated muscle cell differentiation | GO:0051146 | 43 | 0.090 | |
| epithelium development | GO:0060429 | 227 | 0.090 | |
| regulation of dna metabolic process | GO:0051052 | 153 | 0.089 | |
| biomineral tissue development | GO:0031214 | 39 | 0.089 | |
| muscle fiber development | GO:0048747 | 16 | 0.088 | |
| mesenchyme development | GO:0060485 | 59 | 0.086 | |
| tumor necrosis factor production | GO:0032640 | 43 | 0.086 | |
| palate development | GO:0060021 | 13 | 0.086 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 60 | 0.085 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 183 | 0.085 | |
| regulation of protein secretion | GO:0050708 | 86 | 0.085 | |
| regulation of cell motility | GO:2000145 | 299 | 0.085 | |
| negative regulation of protein phosphorylation | GO:0001933 | 140 | 0.083 | |
| negative regulation of phosphorylation | GO:0042326 | 174 | 0.083 | |
| negative regulation of transporter activity | GO:0032410 | 25 | 0.083 | |
| cell cell signaling | GO:0007267 | 155 | 0.082 | |
| negative regulation of chromosome organization | GO:2001251 | 48 | 0.081 | |
| positive regulation of transcription regulatory region dna binding | GO:2000679 | 8 | 0.080 | |
| signal transduction by p53 class mediator | GO:0072331 | 72 | 0.080 | |
| muscle cell development | GO:0055001 | 29 | 0.080 | |
| positive regulation of homeostatic process | GO:0032846 | 47 | 0.080 | |
| ameboidal type cell migration | GO:0001667 | 135 | 0.080 | |
| positive regulation of developmental process | GO:0051094 | 314 | 0.079 | |
| epithelial cell proliferation | GO:0050673 | 128 | 0.079 | |
| nervous system development | GO:0007399 | 293 | 0.078 | |
| cell division | GO:0051301 | 168 | 0.077 | |
| cellular component morphogenesis | GO:0032989 | 314 | 0.077 | |
| digestive tract development | GO:0048565 | 75 | 0.076 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 18 | 0.076 | |
| vasculature development | GO:0001944 | 181 | 0.075 | |
| regulation of cell morphogenesis | GO:0022604 | 153 | 0.075 | |
| cell fate determination | GO:0001709 | 3 | 0.075 | |
| gastrulation | GO:0007369 | 51 | 0.074 | |
| regulation of homeostatic process | GO:0032844 | 121 | 0.074 | |
| actin cytoskeleton organization | GO:0030036 | 207 | 0.074 | |
| response to hypoxia | GO:0001666 | 96 | 0.074 | |
| regulation of locomotion | GO:0040012 | 329 | 0.072 | |
| positive regulation of chromosome organization | GO:2001252 | 41 | 0.071 | |
| cell morphogenesis | GO:0000902 | 296 | 0.071 | |
| muscle cell differentiation | GO:0042692 | 63 | 0.071 | |
| positive regulation of cell division | GO:0051781 | 59 | 0.071 | |
| ossification | GO:0001503 | 121 | 0.070 | |
| muscle structure development | GO:0061061 | 98 | 0.070 | |
| cytokine secretion | GO:0050663 | 64 | 0.070 | |
| regulation of protein acetylation | GO:1901983 | 25 | 0.069 | |
| muscle tissue morphogenesis | GO:0060415 | 19 | 0.068 | |
| regulation of phosphatidylinositol 3 kinase signaling | GO:0014066 | 35 | 0.068 | |
| regulation of epithelial cell proliferation | GO:0050678 | 113 | 0.067 | |
| segmentation | GO:0035282 | 4 | 0.067 | |
| negative regulation of dna metabolic process | GO:0051053 | 57 | 0.067 | |
| negative regulation of ossification | GO:0030279 | 21 | 0.067 | |
| positive regulation of chemokine production | GO:0032722 | 22 | 0.066 | |
| cell development | GO:0048468 | 328 | 0.065 | |
| erythrocyte differentiation | GO:0030218 | 28 | 0.065 | |
| mesoderm morphogenesis | GO:0048332 | 11 | 0.065 | |
| blood vessel development | GO:0001568 | 172 | 0.065 | |
| cardiac septum development | GO:0003279 | 13 | 0.065 | |
| limb development | GO:0060173 | 23 | 0.064 | |
| regulation of chromatin assembly or disassembly | GO:0001672 | 6 | 0.064 | |
| post embryonic development | GO:0009791 | 2 | 0.063 | |
| positive regulation of tumor necrosis factor production | GO:0032760 | 21 | 0.063 | |
| response to decreased oxygen levels | GO:0036293 | 96 | 0.063 | |
| protein secretion | GO:0009306 | 98 | 0.062 | |
| regulation of cell division | GO:0051302 | 116 | 0.062 | |
| fatty acid beta oxidation | GO:0006635 | 22 | 0.061 | |
| heart development | GO:0007507 | 95 | 0.061 | |
| digestive tract morphogenesis | GO:0048546 | 56 | 0.059 | |
| regulation of anatomical structure morphogenesis | GO:0022603 | 286 | 0.059 | |
| regulation of cell development | GO:0060284 | 161 | 0.059 | |
| morphogenesis of an epithelium | GO:0002009 | 60 | 0.058 | |
| regulation of monocyte chemotactic protein 1 production | GO:0071637 | 6 | 0.057 | |
| limb morphogenesis | GO:0035108 | 16 | 0.057 | |
| positive regulation of interleukin 6 production | GO:0032755 | 21 | 0.057 | |
| regulation of peptidyl lysine acetylation | GO:2000756 | 22 | 0.056 | |
| cardiocyte differentiation | GO:0035051 | 23 | 0.056 | |
| regulation of interleukin 6 production | GO:0032675 | 37 | 0.055 | |
| muscle organ development | GO:0007517 | 56 | 0.054 | |
| behavior | GO:0007610 | 112 | 0.054 | |
| head development | GO:0060322 | 108 | 0.054 | |
| regulation of chromosome organization | GO:0033044 | 103 | 0.054 | |
| response to carbohydrate | GO:0009743 | 21 | 0.053 | |
| negative regulation of peptidyl lysine acetylation | GO:2000757 | 8 | 0.053 | |
| generation of neurons | GO:0048699 | 152 | 0.052 | |
| cardiovascular system development | GO:0072358 | 262 | 0.051 | |
| myeloid cell homeostasis | GO:0002262 | 34 | 0.051 | |
| homeostasis of number of cells | GO:0048872 | 40 | 0.050 | |
| multicellular organismal aging | GO:0010259 | 3 | 0.050 | |
| response to growth factor | GO:0070848 | 205 | 0.050 | |
| central nervous system development | GO:0007417 | 123 | 0.050 | |
| negative regulation of protein acetylation | GO:1901984 | 11 | 0.050 | |
| response to oxygen levels | GO:0070482 | 100 | 0.049 | |
| bone morphogenesis | GO:0060349 | 10 | 0.049 | |
| neurogenesis | GO:0022008 | 169 | 0.049 | |
| regulation of skeletal muscle tissue development | GO:0048641 | 15 | 0.048 | |
| regulation of cell aging | GO:0090342 | 18 | 0.048 | |
| phosphatidylinositol mediated signaling | GO:0048015 | 55 | 0.048 | |
| retinoic acid biosynthetic process | GO:0002138 | 2 | 0.048 | |
| immune response | GO:0006955 | 307 | 0.047 | |
| stem cell differentiation | GO:0048863 | 93 | 0.047 | |
| tissue morphogenesis | GO:0048729 | 96 | 0.047 | |
| neural tube development | GO:0021915 | 9 | 0.047 | |
| vesicle mediated transport | GO:0016192 | 371 | 0.047 | |
| striated muscle cell development | GO:0055002 | 27 | 0.046 | |
| growth | GO:0040007 | 202 | 0.046 | |
| circulatory system development | GO:0072359 | 262 | 0.046 | |
| histone methylation | GO:0016571 | 60 | 0.045 | |
| organ morphogenesis | GO:0009887 | 147 | 0.045 | |
| brain development | GO:0007420 | 97 | 0.045 | |
| anatomical structure maturation | GO:0071695 | 9 | 0.045 | |
| regulation of organ morphogenesis | GO:2000027 | 24 | 0.044 | |
| tube development | GO:0035295 | 125 | 0.043 | |
| neuroblast proliferation | GO:0007405 | 4 | 0.043 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.043 | |
| histone phosphorylation | GO:0016572 | 16 | 0.043 | |
| gland development | GO:0048732 | 48 | 0.043 | |
| tube morphogenesis | GO:0035239 | 95 | 0.042 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 213 | 0.042 | |
| regulation of chromatin modification | GO:1903308 | 51 | 0.041 | |
| digestive system development | GO:0055123 | 75 | 0.041 | |
| regulation of chromatin organization | GO:1902275 | 56 | 0.041 | |
| positive regulation of cell differentiation | GO:0045597 | 211 | 0.040 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 48 | 0.040 | |
| regeneration | GO:0031099 | 4 | 0.040 | |
| protein catabolic process | GO:0030163 | 325 | 0.040 | |
| cellular macromolecular complex assembly | GO:0034622 | 324 | 0.040 | |
| embryonic morphogenesis | GO:0048598 | 85 | 0.039 | |
| regulation of histone modification | GO:0031056 | 47 | 0.039 | |
| reproductive process | GO:0022414 | 106 | 0.039 | |
| protein modification by small protein conjugation | GO:0032446 | 342 | 0.039 | |
| appendage development | GO:0048736 | 23 | 0.038 | |
| mesoderm development | GO:0007498 | 14 | 0.038 | |
| mitotic cell cycle process | GO:1903047 | 286 | 0.038 | |
| determination of adult lifespan | GO:0008340 | 2 | 0.038 | |
| negative regulation of catalytic activity | GO:0043086 | 335 | 0.038 | |
| negative regulation of tumor necrosis factor superfamily cytokine production | GO:1903556 | 20 | 0.038 | |
| eye morphogenesis | GO:0048592 | 16 | 0.037 | |
| embryonic skeletal system development | GO:0048706 | 13 | 0.037 | |
| cell morphogenesis involved in differentiation | GO:0000904 | 144 | 0.037 | |
| heart valve morphogenesis | GO:0003179 | 8 | 0.036 | |
| neural crest cell differentiation | GO:0014033 | 5 | 0.036 | |
| chordate embryonic development | GO:0043009 | 34 | 0.036 | |
| pharynx development | GO:0060465 | 1 | 0.035 | |
| actomyosin structure organization | GO:0031032 | 59 | 0.035 | |
| positive regulation of interleukin 6 secretion | GO:2000778 | 6 | 0.035 | |
| locomotory behavior | GO:0007626 | 1 | 0.035 | |
| histone lysine methylation | GO:0034968 | 50 | 0.034 | |
| female gamete generation | GO:0007292 | 2 | 0.034 | |
| inositol lipid mediated signaling | GO:0048017 | 55 | 0.033 | |
| cytoplasmic transport | GO:0016482 | 379 | 0.033 | |
| nucleoside phosphate catabolic process | GO:1901292 | 412 | 0.032 | |
| membrane organization | GO:0061024 | 292 | 0.032 | |
| skeletal system development | GO:0001501 | 79 | 0.032 | |
| regulation of fatty acid oxidation | GO:0046320 | 9 | 0.032 | |
| methylation | GO:0032259 | 106 | 0.032 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 391 | 0.031 | |
| apoptotic signaling pathway | GO:0097190 | 268 | 0.031 | |
| negative regulation of cell cycle | GO:0045786 | 193 | 0.031 | |
| macromolecule methylation | GO:0043414 | 97 | 0.030 | |
| outflow tract morphogenesis | GO:0003151 | 10 | 0.030 | |
| single organism membrane organization | GO:0044802 | 268 | 0.030 | |
| response to monosaccharide | GO:0034284 | 20 | 0.030 | |
| protein processing | GO:0016485 | 226 | 0.030 | |
| neuron migration | GO:0001764 | 11 | 0.030 | |
| cellular macromolecule catabolic process | GO:0044265 | 380 | 0.029 | |
| positive regulation of immune system process | GO:0002684 | 283 | 0.029 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.029 | |
| nitric oxide mediated signal transduction | GO:0007263 | 7 | 0.028 | |
| protein ubiquitination | GO:0016567 | 314 | 0.028 | |
| aging | GO:0007568 | 66 | 0.028 | |
| protein maturation | GO:0051604 | 233 | 0.028 | |
| forebrain generation of neurons | GO:0021872 | 3 | 0.028 | |
| cell adhesion | GO:0007155 | 325 | 0.028 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 411 | 0.028 | |
| oogenesis | GO:0048477 | 2 | 0.028 | |
| limbic system development | GO:0021761 | 3 | 0.028 | |
| developmental maturation | GO:0021700 | 28 | 0.027 | |
| regulation of cell cycle process | GO:0010564 | 266 | 0.027 | |
| response to abiotic stimulus | GO:0009628 | 336 | 0.027 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 119 | 0.027 | |
| protein acetylation | GO:0006473 | 116 | 0.027 | |
| response to hexose | GO:0009746 | 20 | 0.027 | |
| diterpenoid biosynthetic process | GO:0016102 | 2 | 0.027 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 212 | 0.027 | |
| protein polyubiquitination | GO:0000209 | 110 | 0.027 | |
| organophosphate catabolic process | GO:0046434 | 430 | 0.026 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 412 | 0.026 | |
| somitogenesis | GO:0001756 | 2 | 0.026 | |
| cell fate specification | GO:0001708 | 8 | 0.026 | |
| regulation of proteolysis | GO:0030162 | 293 | 0.026 | |
| carboxylic acid biosynthetic process | GO:0046394 | 97 | 0.026 | |
| developmental programmed cell death | GO:0010623 | 3 | 0.026 | |
| epithelial cell differentiation | GO:0030855 | 141 | 0.026 | |
| stem cell division | GO:0017145 | 2 | 0.026 | |
| cardiac left ventricle morphogenesis | GO:0003214 | 6 | 0.025 | |
| single organism reproductive process | GO:0044702 | 98 | 0.025 | |
| biological adhesion | GO:0022610 | 331 | 0.025 | |
| negative regulation of hydrolase activity | GO:0051346 | 182 | 0.025 | |
| microtubule based process | GO:0007017 | 210 | 0.025 | |
| cellular protein catabolic process | GO:0044257 | 261 | 0.025 | |
| tissue regeneration | GO:0042246 | 3 | 0.025 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 206 | 0.024 | |
| intracellular protein transport | GO:0006886 | 270 | 0.024 | |
| glycosyl compound catabolic process | GO:1901658 | 413 | 0.024 | |
| regulation of peptidase activity | GO:0052547 | 180 | 0.024 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 7 | 0.024 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 412 | 0.023 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 392 | 0.023 | |
| rna interference | GO:0016246 | 4 | 0.023 | |
| cellular protein complex assembly | GO:0043623 | 188 | 0.023 | |
| regulation of endopeptidase activity | GO:0052548 | 170 | 0.023 | |
| ras protein signal transduction | GO:0007265 | 73 | 0.023 | |
| response to oxygen containing compound | GO:1901700 | 369 | 0.023 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 175 | 0.022 | |
| cellular response to endogenous stimulus | GO:0071495 | 336 | 0.022 | |
| regulation of cell migration | GO:0030334 | 289 | 0.022 | |
| embryo development | GO:0009790 | 123 | 0.022 | |
| purine ribonucleoside catabolic process | GO:0046130 | 398 | 0.022 | |
| negative regulation of locomotion | GO:0040013 | 118 | 0.022 | |
| purine containing compound catabolic process | GO:0072523 | 411 | 0.022 | |
| modification dependent protein catabolic process | GO:0019941 | 209 | 0.022 | |
| regulation of intracellular transport | GO:0032386 | 195 | 0.022 | |
| wnt signaling pathway | GO:0016055 | 156 | 0.021 | |
| hippocampus development | GO:0021766 | 1 | 0.021 | |
| forebrain neuron differentiation | GO:0021879 | 3 | 0.021 | |
| microtubule cytoskeleton organization | GO:0000226 | 176 | 0.021 | |
| reproduction | GO:0000003 | 63 | 0.021 | |
| endomembrane system organization | GO:0010256 | 196 | 0.020 | |
| chemical homeostasis | GO:0048878 | 306 | 0.020 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 207 | 0.020 | |
| embryonic organ development | GO:0048568 | 36 | 0.020 | |
| secretion | GO:0046903 | 254 | 0.020 | |
| oocyte differentiation | GO:0009994 | 2 | 0.020 | |
| cd4 positive alpha beta t cell differentiation involved in immune response | GO:0002294 | 4 | 0.020 | |
| neural retina development | GO:0003407 | 8 | 0.020 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 391 | 0.020 | |
